The Global Fund is working with partners to rapidly and equitably support access to COVID-19 health products and diagnostics for low- and middle-income countries by following the World Health Organization’s allocation model.
Following the World Health Organization’s interim guidance on antigen-detection in the diagnosis of COVID-19 from 11 September, the Global Fund anticipates being able to support countries in accessing high-performing antigen-detecting rapid diagnost...
Following the World Health Organization guidance Corticosteroids for COVID-19 from 2 September, the Global Fund has confirmed that corticosteroids can be funded through Global Fund grants.
The Global Fund has opened a new channel through wambo.org, the Global Fund’s procurement tool, for Principal Recipients to access quality-assured health products including personal protective equipment as part of their response to COVID-19 and consi...
The Global Fund continues to work closely with our technical partners, especially the Stop TB Partnership's Global Drug Facility and our procurement service agents, as the global response to the COVID-19 pandemic evolves.